IL32 and prostate adenocarcinoma: Gene alteration mapping of IL32 showed that IL32 amplification was the most important single altering factor in PRAD, Renal cell carcinoma, HNSC, LUAD, LUSC, Bone cancer, PAAD and DLBC.We observed the highest frequency of IL32 alterations (> 12%) in patients with BRCA, where “Amplification” was the major type (Fig. 1B).